John R. Donovan

Vorstandsvorsitzender bei Tolerion, Inc.

Health Technology

Finance

Consumer Services

Ursprung des Netzwerks ersten Grades von John R. Donovan

Einheit	Art der Einheit	Industrie
Tolerion, Inc. Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. 5	Holding Company	Pharmaceuticals: Major	5
Arch Oncology, Inc. Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. 1	Holding Company	Miscellaneous Commercial Services	1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von John R. Donovan

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
GILEAD SCIENCES, INC.	Biotechnology	Julie Cherrington Graeme Currie	Corporate Officer/Principal Chief Tech/Sci/R&D Officer
ACUMEN PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Sean Stalfort Stephen Zachary	Director/Board Member Director/Board Member
PatientsLikeMe LLC PatientsLikeMe LLC Internet Software/ServicesTechnology Services PatientsLikeMe LLC operates online health communities for patients. The firm offers data and information on patients, treatments, symptoms and research. The company was founded by Benjamin Heywood, James Heywood and Jeff Cole in 2004 and is headquartered in Cambridge, MA.	Internet Software/Services	Paul Manning	Director/Board Member
Octagon Partners LLC		Sean Stalfort	Corporate Officer/Principal
Gen9, Inc. Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA.	Biotechnology	Paul Manning	Director/Board Member
Stanford University	College/University	Lawrence Steinman Julie Cherrington	Corporate Officer/Principal Doctorate Degree
University of Massachusetts	College/University	Paul Manning Sean Stalfort	Undergraduate Degree Undergraduate Degree
Washington & Lee University	College/University	Stephen Zachary	Undergraduate Degree
PDL BIOPHARMA, INC.	Biotechnology	Graeme Currie	Chief Tech/Sci/R&D Officer
University of Aston	College/University	Graeme Currie	Doctorate Degree
PBM Products LLC PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens.	Food: Meat/Fish/Dairy	Paul Manning Sean Stalfort	Chief Executive Officer Corporate Officer/Principal
The Foundation Fighting Blindness, Inc. The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD.	Miscellaneous Commercial Services	Paul Manning	Director/Board Member
Foundation Fighting Blindness Clinical Research Institute Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD.	Financial Conglomerates	Paul Manning	Director/Board Member
Beta-Pro LLC		Paul Manning	Corporate Officer/Principal
CS First Boston Pacific, Inc.		Sean Stalfort	Corporate Officer/Principal
LYTIX BIOPHARMA	Pharmaceuticals: Major	Graeme Currie	Corporate Officer/Principal
University of Virginia Community Credit Union University of Virginia Community Credit Union Savings BanksFinance University of Virginia Community Credit Union operates as a state chartered credit union. The private company is based in Charlottesville, VA and has subsidiaries in the United States.	Savings Banks	Paul Manning	Corporate Officer/Principal
Enterprise Mortgage Acceptance Co. LLC Enterprise Mortgage Acceptance Co. LLC Miscellaneous Commercial ServicesCommercial Services Enterprise Mortgage Acceptance Co. LLC provides capital and financing options for equipment financing and business loans. The private company is based in Westport, CT and has subsidiaries in the United States.	Miscellaneous Commercial Services	Sean Stalfort	Corporate Officer/Principal
Sands Capital Ventures LLC Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia.	Investment Managers	Stephen Zachary	Private Equity Analyst
PBM Capital Group LLC PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia.	Investment Managers	Paul Manning Sean Stalfort	Chief Executive Officer Chief Executive Officer
CANDEL THERAPEUTICS, INC.	Biotechnology	Paul Manning Sean Stalfort	Chairman Director/Board Member
PBM Pharmaceuticals, Inc. PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA.	Pharmaceuticals: Major	Paul Manning Sean Stalfort	Director/Board Member Director/Board Member
ArcherDX LLC ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO.	Packaged Software	Paul Manning	Director/Board Member
The Johns Hopkins University School of Medicine	College/University	Stephen Zachary	Doctorate Degree
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.	Biotechnology	Graeme Currie	Chief Operating Officer
ADVANZ PHARMA CORP. LIMITED	Pharmaceuticals: Major	Paul Manning	Director/Board Member
DICE THER	Biotechnology	Stephen Zachary	Director/Board Member
Xalud Therapeutics, Inc. Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA.	Biotechnology	Paul Manning Sean Stalfort	Chairman Director/Board Member
VERRICA PHARMACEUTICALS INC.	Pharmaceuticals: Major	Paul Manning Sean Stalfort	Chairman Director/Board Member
Pbm Capital Investments LLC		Paul Manning	Chief Executive Officer
UVA Health Foundation UVA Health Foundation Internet Software/ServicesTechnology Services Part of University of Virginia, UVA Health Foundation operates a healthcare platform. The company is based in Charlottesville, VA.	Internet Software/Services	Paul Manning	Director/Board Member
DOVA PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Paul Manning Sean Stalfort	Chairman Director/Board Member
Quantapore, Inc. Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA.	Biotechnology	Sean Stalfort	Director/Board Member
Day Zero Diagnostics, Inc. Day Zero Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Day Zero Diagnostics, Inc. operates as an infectious disease diagnostic firm. It develops technologies to modernize the treatment for infectious diseases. The company was founded by Jong Leeis, Miriam Huntley, Doug Kwon, Melis Anahtar, and Dougal Maclaurin and is headquartered in Boston, MA.	Miscellaneous Commercial Services	Stephen Zachary	Director/Board Member
Octagon Finance LLC Octagon Finance LLC Financial ConglomeratesFinance Octagon Finance LLC provides financial services. The private company is based in Durham.	Financial Conglomerates	Sean Stalfort	Corporate Officer/Principal
SeLux Diagnostics, Inc. SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA.	Medical Specialties	Stephen Zachary	Director/Board Member
PTC Therapeutics GT, Inc. PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk.	Medical Specialties	Stephen Zachary	Corporate Officer/Principal
Novartis Gene Therapies Switzerland GmbH		Sean Stalfort	Director/Board Member
DICE Molecules SV, Inc. DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.	Investment Managers	Stephen Zachary	Director/Board Member
TAYSHA GENE THERAPIES, INC.	Biotechnology	Paul Manning Sean Stalfort	Director/Board Member Director/Board Member
RareGen LLC RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC.	Miscellaneous Commercial Services	Paul Manning	Director/Board Member
LIQUIDIA CORPORATION	Pharmaceuticals: Major	Paul Manning	Director/Board Member
PASITHEA THERAPEUTICS CORP.	Pharmaceuticals: Major	Lawrence Steinman Graeme Currie	Founder Corporate Officer/Principal
SalioGen Therapeutics, Inc. SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023.	Biotechnology	Sean Stalfort	Director/Board Member
Baxis Pharmaceuticals, Inc.		Sean Stalfort	Director/Board Member
Vetana Animal Health, Inc.		Sean Stalfort	Director/Board Member